Chemistry Reference
In-Depth Information
137.
Villa , R. ; Folini , M. ; Perego , P. ; Supino , R. ; Setti , E. ; Daidone , M.G.
et al.
; Telomerase
activity and telomere length in human ovarian cancer and melanoma cell lines: correla-
tion with sensitivity to DNA damaging agents;
Int. J. Oncol.
, 2000 ,
16
( 5 ), 995 - 1002 .
Jeyapalan , J.C. ; Saretzki , G. ; Leake , A. ; Tilby , M.J.
138.
; von Zglinicki , T. ; Tumour - cell apop-
tosis after cisplatin treatment is not telomere dependent;
Int. J. Cancer
, 2006 ,
118
( 11 ),
2727 - 2734 .
Opresko , P.L. ; Fan , J. ; Danzy , S. ; Wilson , D.M. , 3rd ; Bohr , V.A. ; Oxidative damage in telo-
meric DNA disrupts recognition by TRF1 and TRF2;
Nucleic Acids Res.
, 2005 ,
33
( 4 ),
1230 - 1239 .
Ourliac - Garnier , I. ; Poulet , A. ; Amiard , S. ; Gilson , E. ; Giraud - Panis , M. ; Bombard , S. ;
Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1;
manuscript in preparation 2008.
Chen , J.L. ; Blasco , M.A. ; Greider , C.W. ; Secondary structure of vertebrate telomerase
RNA ;
Cell
, 2000 ,
100
( 5 ), 503 - 514 .
Norton , J.C. ; Piatyszek , M.A. ; Wright , W.E. ; Shay , J.W. ; Corey , D.R. ; Inhibition of human
telomerase activity by peptide nucleic acids;
Nat. Biotechnol.
, 1996 ,
14
( 5 ), 615 - 619 .
Keppler , B.R. ; Jarstfer , M.B. ; Inhibition of telomerase activity by preventing proper
assemblage ;
Biochemistry
, 2004 ,
43
( 2 ), 334 - 343 .
Keppler , B.R. ; Jarstfer , M.B. ; A high - throughput assay for a human telomerase protein -
human telomerase RNA interaction;
Anal. Biochem.
, 2006 ,
353
( 1 ), 75 - 82 .
Herbert , B.S. ; Gellert , G.C. ; Hochreiter , A. ; Pongracz , K. ; Wright , W.E ; Zielinska , D.
et
al.
; Lipid modifi cation of GRN163, an N3′ - > P5 ′ thio - phosphoramidate oligonucleotide,
enhances the potency of telomerase inhibition;
Oncogene
, 2005 ,
24
( 33 ), 5262 - 5268 .
Gellert , G.C. ; Dikmen , Z.G. ; Wright , W.E. ; Gryaznov , S. ; Shay , J.W. ; Effects of a novel
telomerase inhibitor, GRN163L, in human breast cancer;
Breast Cancer Res. Treat.
, 2006 ,
96
( 1 ), 73 - 81 .
Colangelo , D. ; Osella , D. ; Telomerase inhibition and cancer: might platinum based drugs
have a future as anti- telomerase pharmacological approach? ;
Curr. Med. Chem.
, 2005 ,
12
( 26 ), 3091 - 3102 .
Colangelo , D. ; Ghiglia , A.L. ; Viano , I. ; Cavigiolio , G. ; Osella , D . ;
Cis
- [Pt(Cl)2(pyridine)(5 -
SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme;
Biometals
,
2003 ,
16
( 4 ), 553 - 560 .
Furuta , M. ; Nozawa , K. ; Takemura , M. ; Izuta , S. ; Murate , T. ; Tsuchiya , M.
et al.
; A novel
platinum compound inhibits telomerase activity in vitro and reduces telomere length in
a human hepatoma cell line;
Int. J. Cancer
, 2003 ,
104
( 6 ), 709 - 715 .
Kim , N.W. ; Piatyszek , M.A. ; Prowse , K.R. ; Harley , C.B. ; West , M.D. ; Ho , P.L.
et al.
; Specifi c
association of human telomerase activity with immortal cells and cancer [see comments];
Science
, 1994 ,
266
( 5193 ), 2011 - 2015 .
Knox , R.J. ; Friedlos , F. ; Lydall , D.A. ; Roberts , J.J. ; Mechanism of cytotoxicity of antican-
cer platinum drugs: evidence that
cis
- diamminedichloroplatinum(II) and
cis
- diammine -
(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction
with DNA;
Cancer Res.
, 1986 ,
46
( 4 Pt 2 ), 1972 - 1979 .
Ishibashi , T. ; Lippard , S.J. ; Telomere loss in cells treated with cisplatin ;
Proc. Natl. Acad.
Sci. USA
, 1998 ,
95
( 8 ), 4219 - 4223 .
Zhang , R.G. ; Zhang , R.P. ; Wang , X.W. ; Xie , H. ; Effects of cisplatin on telomerase activity
and telomere length in BEL-7404 human hepatoma cells;
Cell Res.
, 2002 ,
12
( 1 ), 55 - 62 .
Ishii , K. ; Yang , W.L. ; Cvijic , M.E. ;
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
Kikuchi , Y. ; Nagata , I. ; Chin , K.V. ; Telomere shortening
by cisplatin in yeast nucleotide excision repair mutant;
Exp. Cell Res.
, 2000 ,
225
,
95 - 101 .
Brabec , V. ; Kasparkova , J. ; Modifi cations of DNA by platinum complexes. Relation to
resistance of tumors to platinum antitumor drugs;
Drug Resist. Updat.
, 2005 ,
8
( 3 ),
131 - 146 .
Sedletska , Y. ; Giraud - Panis , M.J. ; Malinge , J.M. ; Cisplatin is a DNA-damaging
antitumour compound triggering multifactorial biochemical responses in cancer cells:
importance of apoptotic pathways;
Curr, Med. Chem. Anticancer Agents
, 2005 ,
5
( 3 ),
251 - 265 .
155.
156.
